TRACKER Celebrates Its First Peer-Reviewed Publication
- TRACKER Biobank
- Jul 28
- 1 min read
Congratulations to Dr. Sarah Yeo, PhD candidate and respiratory specialist, on her first first-author publication, and to the TRACKER team on achieving our very first peer-reviewed paper, now published in the Medical Journal of Australia (MJA).
Lung Cancer Biobanking: Challenges and Future Directions
Dr. Yeo’s publication, titled “Lung cancer biobanking in Australia: challenges and future directions,” explores how biobanks are transforming the way we study and treat lung cancer, Australia’s deadliest cancer.
Biobanks like TRACKER play a vital role in advancing lung cancer research by collecting high-quality patient samples and clinical data. These resources allow researchers to tackle key questions, including:
Why some patients respond to treatment while others don’t
How lung cancer can be detected earlier and more accurately
What new biomarkers could guide more personalised therapies
By connecting patients, clinicians, and researchers, biobanks provide the foundation for discoveries that lead to better diagnostics, new treatment strategies, and improved patient outcomes.
Building a National Framework for Impact
In the article, Dr. Yeo and co-authors highlight both the challenges and opportunities facing Australia’s lung cancer biobanking landscape. From developing sustainable funding models to ensuring equitable access and diverse participation, the paper calls for a coordinated national approach to strengthen collaboration and maximise impact.
A Collaborative Achievement
This publication was made possible through the collaboration of our colleagues at the Olivia Newton-John Cancer Research Institute (ONJCRI), Austin Health, The University of Melbourne and Lung Foundation Australia.
We’re incredibly proud of Dr. Yeo and the entire TRACKER team for this achievement. We’re only just getting started!
Read the full article in the Medical Journal of Australia:
Comments